Five years ago Hong Kong, once a center of international finance, was demoted by the European Union as a financial regulatory area on a similar footing. Beida accounting professor Paul Gillis applauds that after five years the HK legislators start to move to reform the auditors, but feels the action is far from enough, he writes on his weblog.
Spinoffs are typically business transactions where the total of all entities increase their value by splitting up their existing business. But not so for Chinese companies, listed in the US, argues Beida accounting professor Paul Gillis. Not the shareholders or the company gains, but mostly management, he explains at his weblog.
China’s financial authorities might be wary of Bitcoins and other digital currencies, but the country is embracing the underlying blockchain technology. Self-driving cars, agriculture, retail and other industries use the deep pockets of the government to introduce the new technology.
At the China Speakers Bureau, we offer a range of speakers who can help you to make sense out of this new direction China is taking, leading the way for global innovation.
ZTE got itself into trouble by violating a ban on using American components for products it exported to Iran and North-Korea. The punishment – no US components for ZTE for seven years – might kill the Chinese company, who cannot work without them. What did the auditors do, wonders Beida auditing professor Paul Gillis on his weblog.
Beida accounting professor Paul Gillis describes on his weblog how auditor KPMG Hong Kong got itself into trouble for signing off papers on China Medical, a company convicted in 2012 for looting US$400 million from its investors. Problem: KPMG Hong Kong was not really in charge and now the Hong Kong legal system caught up with this omission.
Many Chinese companies took a listing at US exchanges because audits in Hong Kong and on mainland exchanges were stricter. The HK stock market now is watering down regulations for audits, notes Beida accounting professor Paul Gillis on his website to his shock, to pull back those Chinese companies from the US.
Foreign companies fear an increasing risk in China, now the government is tightening legal supervision, fighting corruption and banning business practices that were considered to be common up to a year ago. GSK might be one of the high-profile cases in the anti-corruption drive, but no foreign company or industry is not worried about those changes. The China Speakers Bureau can offer a range of experts on risk management in China.
China and the US worked out a deal on the age-old argument where Chinese firms are not allowed to hand over paperwork to US institutions for audits. But the agreement is not valid for Hong Kong, and so close to a hundred current and former KPMG partners got sued over the case of the bankrupt China Medical, reports Beida accounting professor Paul Gillis last week at his weblog.